Lee's Pharmaceutical Holdings Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 1,137

Employees

  • Stock Symbol
  • 00950

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $0.13
  • (As of Friday Closing)

Lee's Pharmaceutical Holdings General Information

Description

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue; and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1/F, Building 20E, Phase 3
  • Hong Kong Science Park
  • Hong Kong
  • Hong Kong
+852 2314
Primary Industry
Pharmaceuticals
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Stock Exchange
HKG
Corporate Office
  • 1/F, Building 20E, Phase 3
  • Hong Kong Science Park
  • Hong Kong
  • Hong Kong
+852 2314

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lee's Pharmaceutical Holdings Stock Performance

As of 13-Nov-2026, Lee's Pharmaceutical Holdings’s stock price is $0.13. Its current market cap is $78.8M with 589M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.13 $0.13 $0.13 - $0.24 $78.8M 589M 555K $0.03

Lee's Pharmaceutical Holdings Financials Summary

As of 30-Jun-2026, Lee's Pharmaceutical Holdings has a trailing 12-month revenue of $197M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 53,731 91,132 103,344 110,623
Revenue 196,837 184,187 179,408 134,501
EBITDA 13,178 30,476 33,003 24,272
Net Income 15,331 11,793 11,931 2,133
Total Assets 444,099 445,143 337,202 369,920
Total Debt 31,864 39,873 29,278 26,124
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lee's Pharmaceutical Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lee's Pharmaceutical Holdings‘s full profile, request access.

Request a free trial

Lee's Pharmaceutical Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lee's Pharmaceutical Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lee's Pharmaceutical Holdings‘s full profile, request access.

Request a free trial

Lee's Pharmaceutical Holdings Investments & Acquisitions (7)

Lee's Pharmaceutical Holdings’s most recent deal was a Merger/Acquisition with Alexza Pharmaceuticals (Staccato One Breath Platform Technology). The deal was made on 13-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alexza Pharmaceuticals (Staccato One Breath Platform Technology) 13-Dec-2025 Merger/Acquisition Drug Delivery
Aimwell Partners 16-Feb-2023 Reverse Merger Automotive
Zhaoke Ophthalmology 30-Oct-2020 Early Stage VC Pharmaceuticals
Windtree Therapeutics 04-Apr-2018 PIPE Biotechnology
Dilafor 27-Sep-2016 Later Stage VC Drug Discovery
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Lee's Pharmaceutical Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Lee's Pharmaceutical Holdings’s complete esg history, request access »

Lee's Pharmaceutical Holdings Exits (4)

Lee's Pharmaceutical Holdings’s most recent exit was on 30-Oct-2020 from Zhaoke Ophthalmology. The exit was categorized as with 13 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Zhaoke Ophthalmology 30-Oct-2020 Completed
  • 13 buyers
Windtree Therapeutics 04-Apr-2018 Completed
FiberSense (Monitoring Equipment) 27-Nov-2014 Completed
  • 4 buyers
CVie Therapeutics Company 07-Aug-2012 Joint Venture Completed
To view Lee's Pharmaceutical Holdings’s complete exits history, request access »

Lee's Pharmaceutical Holdings Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
CVie Therapeutics Company Taipei, Taiwan 2012

Lee's Pharmaceutical Holdings FAQs

  • When was Lee's Pharmaceutical Holdings founded?

    Lee's Pharmaceutical Holdings was founded in 1994.

  • Where is Lee's Pharmaceutical Holdings headquartered?

    Lee's Pharmaceutical Holdings is headquartered in Hong Kong, Hong Kong.

  • What is the size of Lee's Pharmaceutical Holdings?

    Lee's Pharmaceutical Holdings has 1,137 total employees.

  • What industry is Lee's Pharmaceutical Holdings in?

    Lee's Pharmaceutical Holdings’s primary industry is Pharmaceuticals.

  • Is Lee's Pharmaceutical Holdings a private or public company?

    Lee's Pharmaceutical Holdings is a Public company.

  • What is Lee's Pharmaceutical Holdings’s stock symbol?

    The ticker symbol for Lee's Pharmaceutical Holdings is 00950.

  • What is the current stock price of Lee's Pharmaceutical Holdings?

    As of 13-Nov-2026 the stock price of Lee's Pharmaceutical Holdings is $0.13.

  • What is the current market cap of Lee's Pharmaceutical Holdings?

    The current market capitalization of Lee's Pharmaceutical Holdings is $78.8M.

  • What is Lee's Pharmaceutical Holdings’s current revenue?

    The trailing twelve month revenue for Lee's Pharmaceutical Holdings is $197M.

  • What is Lee's Pharmaceutical Holdings’s annual earnings per share (EPS)?

    Lee's Pharmaceutical Holdings’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process